The latest breast cancer news
Browsing: Breast Cancer
Experimental treatment shows promise against triple-negative breast cancer
By simultaneously tackling two mechanisms for cancer’s growth, an experimental therapy reduced the spread of…
SABCS 2018: Adjuvant capecitabine did not significantly improve outcomes for patients with early-stage triple-negative breast cancer
Treating patients who had early-stage triple-negative breast cancer with the chemotherapy agent capecitabine after they…
SABCS 2018: Adjuvant chemotherapy might not add benefit in breast cancer patients who have excellent response to neoadjuvant chemotherapy
Pathological complete response (pCR) after neoadjuvant (presurgery) chemotherapy was associated with significantly lower recurrence risk…
SABCS 2018: Phase III KATHERINE clinical trial crossed early reporting boundary and met its primary endpoint
Substituting trastuzumab emtansine (T-DM1, Kadcyla) for adjuvant trastuzumab (Herceptin) in patients who had residual disease…
SABCS 2018: Delaying adjuvant chemotherapy associated with worse outcomes for patients with triple-negative breast cancer
Patients with triple-negative breast cancer who delayed starting adjuvant chemotherapy for more than 30 days…
Black breast cancer patients have worse outcomes than whites, despite similar treatments
Black women with the most common form of early breast cancer had worse outcomes than…
SABCS 2018: Low-dose tamoxifen was safe and effective at reducing recurrence and new breast disease for patients with DCIS, LCIS, and ADH
Treatment with a low dose of tamoxifen (5 mg per day) halved the risk of…
SABCS 2018: Circulating tumour cell count could help choose treatment for metastatic breast cancer patients
Circulating tumour-cell (CTC) count could be used to choose hormone therapy or chemotherapy as frontline…
SABCS 2018: Axillary radiotherapy and lymph node surgery yielded comparable 10-year outcomes for patients with breast cancer
Patients with early-stage breast cancer who had cancer detected in a sentinel lymph node biopsy…
SABCS 2018: Liquid biopsies in SOLAR-1 trial predict benefit of alpelisib in PIK3CA-mutant breast cancer
Liquid biopsy-based assessment of PIK3CA mutational status served as a better indicator of progression-free survival…